Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New chemo combo shows promise against aggressive breast cancer

NCT ID NCT03301350

First seen Feb 15, 2026 · Last updated May 23, 2026 · Updated 10 times

Summary

This study tested a specific chemotherapy combination given before surgery in 29 people with triple-negative breast cancer, a fast-growing type. The goal was to see if the treatment could completely clear all cancer from the breast and nearby lymph nodes. Researchers measured how many participants had no cancer left at the time of surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Aspirus Regional Cancer Center Wausau

    Wausau, Wisconsin, 54401, United States

  • Columbia St. Mary's Cancer Center

    Milwaukee, Wisconsin, 53211, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • ProHealth Care

    Waukesha, Wisconsin, 53188, United States

  • Swedish American Hospital

    Rockford, Illinois, 61104, United States

  • University of Wisconsin Carbone Cancer Center

    Madison, Wisconsin, 53792, United States

Conditions

Explore the condition pages connected to this study.